Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
作者信息
Sahai J, Gallicano K, Swick L, Tailor S, Garber G, Seguin I, Oliveras L, Walker S, Rachlis A, Cameron D W
机构信息
University of Ottawa, Ottawa General Hospital, Ontario, Canada.
出版信息
Ann Intern Med. 1997 Aug 15;127(4):289-93. doi: 10.7326/0003-4819-127-4-199708150-00006.
BACKGROUND
Reports suggest that antituberculosis drugs are malabsorbed in patients with advanced HIV disease.
OBJECTIVE
To evaluate the pharmacokinetics of antituberculosis agents in HIV-seropositive patients at different stages of disease.
DESIGN
Parallel study.
SETTING
Two hospital outpatient clinics.
PARTICIPANTS
12 healthy volunteers, 12 patients with asymptomatic HIV disease, 12 patients with symptomatic HIV disease, and 12 patients with symptomatic HIV disease and diarrhea.
MEASUREMENTS
Drug plasma concentrations were measured over 24 hours on day 4 of concurrent therapy.
INTERVENTION
Oral isoniazid (300 mg/d), rifampin (600 mg/d), pyrazinamide (1000 mg/d), and ethambutol (1000 mg/d).
RESULTS
Reduced total drug exposure to rifampin and pyrazinamide was associated with D-xylose malabsorption in persons with HIV infection or AIDS. Peak drug exposure to isoniazid was lower in patients with diarrhea.
CONCLUSIONS
Reduced total drug exposure may be related to malabsorption in persons with HIV infection or AIDS.
Zotero 插件